Literature DB >> 28686996

Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety.

T Srinivasa Reddy1, Steven H Privér1, Nedaossadat Mirzadeh2, Suresh K Bhargava3.   

Abstract

We report the application of cationic tri- and tetra-nuclear gold(I) phosphine complexes [Au3(μ-dppen)3]X3 and [Au4(μ-dppa)4]X4 (X=OTf, PF6) [OTf=trifluoromethanesulfonate, dppen=trans-1,2-bis(diphenylphosphino)ethene, dppa=bis(diphenylphosphino)acetylene] for cancer treatment. The results of cytotoxicity tests on four different cancer cells [prostate (DU145), cervical (HeLa), breast (MDAMB-231) and fibro sarcoma (HT1080)] indicate these complexes possess remarkable tumor cell growth inhibitory effects and high selectivity towards cancer cells. The anti-tumor mechanism of the tri- and tetra-nuclear gold(I) complexes has also been investigated.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-cancer activity; Apoptosis; Gold phosphine complexes; Thioredoxin reductase

Mesh:

Substances:

Year:  2017        PMID: 28686996     DOI: 10.1016/j.jinorgbio.2017.06.010

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents.

Authors:  Jong Hyun Kim; Evan Reeder; Sean Parkin; Samuel G Awuah
Journal:  Sci Rep       Date:  2019-08-26       Impact factor: 4.379

Review 2.  Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules.

Authors:  Rossana Galassi; Lorenzo Luciani; Junbiao Wang; Silvia Vincenzetti; Lishan Cui; Augusto Amici; Stefania Pucciarelli; Cristina Marchini
Journal:  Biomolecules       Date:  2022-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.